PTC Therapeutics Inc. buy Royal Bank of Canada
Start price
22.04.25
/
50%
€41.60
Target price
22.04.26
€56.55
Performance (%)
47.84%
Price
19.01.26
€61.50
Summary
This prediction is currently active. With a performance of 47.84% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 22.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -6.061% | -6.061% |
| iShares Core DAX® | -1.875% | 2.861% |
| iShares Nasdaq 100 | -2.177% | 0.048% |
| iShares Nikkei 225® | -0.867% | 6.987% |
| iShares S&P 500 | -1.253% | 1.248% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $65.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€61.50
05.11.25
05.11.25
€71.35
05.11.26
05.11.26
1.63%
19.01.26
19.01.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.20
07.05.25
07.05.25
€51.13
07.05.26
07.05.26
72.65%
19.01.26
19.01.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.40
18.02.25
18.02.25
€60.28
18.02.26
18.02.26
31.86%
19.01.26
19.01.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.60
03.12.24
03.12.24
€59.86
03.12.25
03.12.25
28.02%
04.12.25
04.12.25